Increased numbers of clinical trials, many of which are large, multicenter,
and sometimes international, and the marked shift of funding for clinical
trials to industry have made apparent the inadequacy of mechanisms for protecting
human subjects that were developed when clinical research was generally carried
out on a small scale at single institutions. To address concerns regarding
the protection of human subjects, a group of professionals with expertise
in various aspects of clinical trials was assembled in May 2000. Participants
described and evaluated the mechanisms by which clinical trials are monitored,
focusing on adverse event reporting and the processes by which various parties
with oversight responsibilities interact in the course of these trials. In
this article, we describe the manner in which adverse event reporting might
function to enhance safety and the role of data monitoring committees in using
aggregate data from these reports, outline the problems that now exist for
institutional review boards as they are faced with multiple adverse event
reports from clinical trials while conducting continuing review, and offer
recommendations for improving the current approach.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 58
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.